A
Acadi
Fi
Courses
Knowledge Hub
Community
Practice
Pricing
About
Search
⌘K
Question Bank
/
CFA
/
Level I
/
Equity Investments
Equity Investments
Medium
Windcrest Analytics observes that Novus Pharma has a trailing P/E of 22x, an expected earnings growth rate of 15%, and a PEG ratio of 1.47. Compared to its peer Helion Biotech, which has a PEG ratio of 0.90, which statement is most accurate?
A
Helion Biotech appears relatively undervalued because its PEG ratio is below 1.0, suggesting the market is not fully pricing its growth
B
Novus Pharma appears relatively undervalued because its higher P/E reflects superior quality
C
Both companies are fairly valued because PEG ratios are unreliable for pharmaceutical companies
D
Novus Pharma is undervalued because a PEG ratio above 1.0 indicates a margin of safety
Select an answer to continue
Tags
#peg-ratio
#relative-valuation
#price-earnings
More Equity Investments questions
Start full Level I quiz
CFA Level I — Equity Investments Practice Question | AcadiFi | AcadiFi